Cysteine
- Generic Name
- Cysteine
- Brand Names
- Elcys, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Nouress, Premasol, Primene, Procalamine 3, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7NO2S
- CAS Number
- 52-90-4
- Unique Ingredient Identifier
- K848JZ4886
- Background
A thiol-containing non-essential amino acid that is oxidized to form cystine.
- Indication
For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen
- Associated Therapies
- Total parenteral nutrition therapy, Amino acid supplementation
N-Acetylcysteine Protection Against Radiation Induced Cellular Damage
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Centro Cardiologico Monzino
- Target Recruit Count
- 550
- Registration Number
- NCT04154982
- Locations
- 🇮🇹
Centro Cardiologico Monzino, Milano, MI, Italy
N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.
Not Applicable
- Conditions
- Chronic Thromboembolic Pulmonary Hypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Instituto Nacional de Cardiologia Ignacio Chavez
- Target Recruit Count
- 34
- Registration Number
- NCT04081012
- Locations
- 🇲🇽
Instituto Nacional Ignacio Chavez, Ciudad de mexico, Mexico
Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents
Phase 2
Completed
- Conditions
- Self-HarmDepressionSuicide
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 44
- Registration Number
- NCT04005053
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
- First Posted Date
- 2019-04-03
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 160
- Registration Number
- NCT03900988
- Locations
- 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong
Supportive Measures in Treatment of Aluminum Phosphide Poisoning
Phase 4
Completed
- Conditions
- Detection of Different Prognostic Factors and Their Relation With the OutcomeUsing New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning
- Interventions
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 44
- Registration Number
- NCT03879356
NAC Effect on Hox Genes Expressions in RIF
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 40
- Registration Number
- NCT03862586
N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial
Not Applicable
Completed
- Conditions
- Liver Cirrhoses
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 100
- Registration Number
- NCT03759158
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
Phase 3
- Conditions
- Contrast-induced NephropathyCoronary Artery AngiographyStable AnginaCoronary CatheterizationCoronary Artery DiseaseAcute Coronary Syndrome
- Interventions
- Drug: Placebo oral capsuleDrug: PlacebosDrug: Normal Saline Flush, 0.9% Injectable Solution
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Target Recruit Count
- 1000
- Registration Number
- NCT03755700
- Locations
- 🇮🇷
Rajaie cardiovascular medical and research center, Tehran, Iran, Islamic Republic of
Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression
Early Phase 1
Completed
- Conditions
- Bipolar DisorderDepression
- Interventions
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Martin Lan
- Target Recruit Count
- 3
- Registration Number
- NCT03730064
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- The Aurum Institute NPC
- Target Recruit Count
- 110
- Registration Number
- NCT03702738
- Locations
- 🇹🇿
NIMR-Mbeya Medical Research Centre, Mbeya, Tanzania
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath